GeneDx Holdings Corp (WGS)
19.61
-0.78
(-3.83%)
USD |
NASDAQ |
May 31, 16:00
19.66
+0.05
(+0.25%)
After-Hours: 20:00
GeneDx Holdings Cash from Financing (Quarterly): -0.438M for March 31, 2024
Cash from Financing (Quarterly) Chart
Historical Cash from Financing (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | -0.438M |
| December 31, 2023 | 47.10M |
| September 30, 2023 | -0.911M |
| June 30, 2023 | 7.388M |
| March 31, 2023 | 132.66M |
| December 31, 2022 | 0.065M |
| September 30, 2022 | -0.647M |
| Date | Value |
|---|---|
| June 30, 2022 | 198.06M |
| March 31, 2022 | -0.16M |
| December 31, 2021 | -1.029M |
| September 30, 2021 | 499.40M |
| June 30, 2021 | -2.369M |
| March 31, 2021 | -2.278M |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (Quarterly) Range, Past 5 Years
-2.369M
Minimum
Jun 2021
499.40M
Maximum
Sep 2021
67.45M
Average
-0.16M
Median
Mar 2022
Cash from Financing (Quarterly) Benchmarks
| GE HealthCare Technologies Inc | -153.00M |
| Spok Holdings Inc | -9.814M |
| Ontrak Inc | -0.005M |
| DarioHealth Corp | 20.21M |
| FOXO Technologies Inc | 0.692M |
Cash from Financing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -16.41M |
| Cash from Investing (Quarterly) | 0.843M |
| Free Cash Flow | -146.69M |
| Free Cash Flow Per Share (Quarterly) | -0.6468 |
| Free Cash Flow to Equity (Quarterly) | -15.96M |
| Free Cash Flow to Firm (Quarterly) | -16.26M |
| Free Cash Flow Yield | -29.00% |